Patients with advanced osteosarcoma often experience severe pain that significantly impacts their quality of life, making pain management and comfort care crucial. This study aims to explore key ...

Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

A wearable, remote electrical neuromodulation device was safe and well-tolerated among individuals aged 12 years and older, ...

Researchers examined how the timing of remote electrical neuromodulation treatment affected pain relief, functional disability, and migraine-associated symptom outcomes.

Researchers performed a systematic review and meta-analysis to explore the therapeutic role and safety of low-dose naltrexone for treating fibromyalgia.

QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of neurodegenerative and ...

DuBois, PA / / August 13, 2025 / Highroad Enterprises Key Takeaways Chronic pain affects 50 million Americans, with holistic approaches offering fewer side effects than traditional pain medications.

Preliminary data from a longitudinal study suggest that intensive interdisciplinary pain treatment (IIPT) may significantly enhance endogenous pain modulation, including offset analgesia and pain ...

Nearly impossible to measure, quantify, convey, pain is a truly mysterious human sensation. For the last 25 years in my life as a neurosurgeon, I have seen a lot of pain and suffering firsthand, so ...

Study highlights novel epigenomic modulation in the central nervous system as a key mechanism for SRP-001's analgesic effects Data further supports SRP-001's unique positioning as a safer, non-opioid, ...